メインコンテンツに移動


Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
クイックコネクト

Cardiovascular API

Cardiovascular API

Cardiovascular API
Cardiovascular API

Get access to Dr. Reddys largest Cardiovascular API portfolios to support your formulation success.

Dr. Reddy's offers a wide selection of cardiovascular active pharmaceutical ingredients used in the production of formulations to treat cardiovascular diseases. Our portfolio includes a broad class of cardiovascular molecules: HMG–CoA reductase inhibitors (statins), adenosine triphosphate-citrate lyase (ACL) inhibitors, calcium channel blockers, angiotensin II receptor antagonists, anticoagulants, beta-blockers, lipid modifiers, and others.
Dr. Reddy's is well-positioned to meet the global demands of Cardiovascular APIs. As a Cardiovascular API manufacturer and supplier, we follow a multistage synthesis to ensure supply chain sustainability and compliance with global regulatory requirements. In addition, Dr. Reddy's has established solid strategic sourcing, logistics partnerships and works closely with our customers to successfully manage the capacities of our manufacturing units ahead of launches.
Look at Dr. Reddy's broad selection of active pharmaceutical ingredients cardiovascular drugs used to treat cardiovascular diseases like hypertension, angina, benign prostate hyperplasia, pulmonary arterial hypertension, heredity angioedema, and many more.

Anti-hypertensives

Anti-hypertensives  - Dr. Reddy’s

*Countries referred in the above graphic denotes DMF filing geographies

Anti-platelet

Anti-platelet  - Dr. Reddy’s

*Countries referred in the above graphic denotes DMF filing geographies

Anti-anemic

Anti-anemic - Dr. Reddy’s

*Countries referred in the above graphic denotes DMF filing geographies

Anti-coagulants

Anti-coagulants - Dr. Reddy’s

*Countries referred in the above graphic denotes DMF filing geographies

Pulmonary arterial hypertension (PAH)

Pulmonary arterial hypertension (PAH) - Dr. Reddy’s

*Countries referred in the above graphic denotes DMF filing geographies

Lipid modifying agents

Lipid modifying agents - Dr. Reddy’s

*Countries referred in the above graphic denotes DMF filing geographies

Anti-Angina

Anti-Angina - Dr. Reddy’s

*Countries referred in the above graphic denotes DMF filing geographies

Hereditary Angioedema

Hereditary Angioedema - Dr. Reddy’s

*Countries referred in the above graphic denotes DMF filing geographies

Cardiovascular (transthyretin amyloidosis with polyneuropathy)

Cardiovascular (transthyretin amyloidosis with polyneuropathy) - Dr. Reddy’s

*Countries referred in the above graphic denotes DMF filing geographies

USPs of Cardiovascular API

  • Well-controlled impurity profile (APIs meets current and future stringent impurity limits).
  • Improved API flow property through controlled crystallization and process modifications to ease formulation development.
  • Completely backward integrated on the KSMs to ensure uninterrupted supplies.
  • Robust and sustainable supply chain.
  • Eligible to file DMF’s globally in all the markets.
  • Comprehensive assessment of synthetic routes and all toxicological attributes.
  • All GTIs are controlled below TTC limits.
  • Robust advanced analytical techniques to detect potential nitrosamine impurities.
  • Process development through QBD approach.
  • Customized particle sizes (PSD) to meet formulation requirements.
  • Successful BE/dossier filing record of accomplishment in the markets.
  • Multiple synthetic steps manufactured in-house.
  • API and KSM process with no IP Issues.
  • Comprehensive assessment of synthetic routes and all toxicological attributes.
Cardiovascular Products

Bempedoic Acid

治療領域
抗高血圧, 心臓血管

Candesartan Cilexitil

治療領域
抗高血圧, 心臓血管

Enalaprilat

治療領域
抗高血圧, 心臓血管

Tafamidis Free Acid

治療領域
心臓血管

Tafamidis Meglumine

治療領域
心臓血管

アトルバスタチンカルシウム(P型)

治療領域
脂質降下薬, 心臓血管

アトルバスタチンカルシウム(非晶質)

治療領域
脂質降下薬, 心臓血管

アトルバスタチンカルシウム三水和物(1型)

治療領域
脂質降下薬, 心臓血管

イカンチバント酢酸塩

治療領域
遺伝性血管性浮腫, 心臓血管

イルベサルタン

治療領域
抗高血圧, 心臓血管

エナラプリルマレイン酸塩

治療領域
抗高血圧, 心臓血管

コハク酸メトプロロール

治療領域
抗高血圧, 心臓血管

サクビトリルバルサルタン

治療領域
抗高血圧, 心臓血管

テルミサルタン

治療領域
抗高血圧, 心臓血管

ドキサドシンメシル酸塩

治療領域
抗高血圧, 前立腺肥大症(BPH), 心臓血管

トレプロスチニル

治療領域
肺動脈高血圧症(PAH), 心臓血管

バルサルタン

治療領域
抗高血圧, 心臓血管

べシル酸アムロジピン

治療領域
抗高血圧, 心臓血管

ラシジピン

治療領域
抗高血圧, 心臓血管

ラノラジン

治療領域
抗狭心症, 心臓血管

ラミプリル

治療領域
抗高血圧, 心臓血管

ロサルタンカリウム

治療領域
抗高血圧, 心臓血管

Explore other Therapeutic categories.

X

API
Active Pharmaceutical Ingredients

API Supplier of the Year

Global Generics & Biosimilars Awards 2021 winner for 3 consecutive years!

Explore our Products